Trial intelligence / Profile preview

Propranolol and enalapril for prognosis in severe isolated brain trauma

IRCT20210514051289N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of propranolol and enalapril in traumatic brain injury (TBI) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Glasgow Outcome Scale. Started Nov 2021; status: completed.

02

Drugs

propranololenalapril
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on IRCT20210514051289N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210514051289N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call